Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Andrea Mohn-Staudner"'
Autor:
Otto C Burghuber, Klaus Kirchbacher, Andrea Mohn-Staudner, Maximilian Hochmair, Marie-Kathrin Breyer, Michael Studnicka, Michael Rolf Mueller, Petra Feurstein, Andrea Schrott, Bernd Lamprecht, Josef Eckmayr, Friedrich Renner, Josef Bolitschek, Wolfgang Pohl, Peter Schenk, Peter Errhalt, Peter Cerkl, Bernhard Baumgartner, Meinhard Kneussl, Sylvia Hartl
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Objectives: The Austrian Lung Cancer Audit (ALCA) is a pilot study to evaluate clinical and organizational factors related to lung cancer care across Austria. Materials and methods: The ALCA is a prospective, observational, noninterventional cohort s
Externí odkaz:
https://doaj.org/article/73d532ae76714f8d90691f9284006e19
Autor:
Marina Chiara Garassino, Byoung-Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, Hervé Lena, Jesus Corral Jaime, Jhanelle E Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross A Soo, Yifan Huang, Catherine Wadsworth, Phillip A Dennis, Naiyer A Rizvi, Luis Paz-Ares Rodriguez, Silvia Novello, Sandrine Hiret, Peter Schmid, Eckart Laack, Raffaele Califano, Makoto Maemondo, Sang-We Kim, Jamie Chaft, David Vicente Baz, Thierry Berghmans, Dong-Wan Kim, Veerle Surmont, Martin Reck, Ji-Youn Han, Esther Holgado Martin, Cristobal Belda Iniesta, Yuichiro Oe, Antonio Chella, Akhil Chopra, Gilles Robinet, Hector Soto Parra, Michael Thomas, Parneet Cheema, Nobuyuki Katakami, Wu-Chou Su, Young-Chul Kim, Juergen Wolf, Jong-Seok Lee, Hideo Saka, Michele Milella, Inmaculada Ramos Garcia, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, Ernst Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Remi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoine Italiano, Dariusz Kowalski, Fabrice Barlesi, Yuh-Min Chen, David Spigel, Busyamas Chewaskulyong, Ramon Garcia Gomez, Rosa Alvarez Alvarez, Chih-Hsin Yang, Te-Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Koichi Goto, Joaquim Bosch-Barrera, Glen Weiss, Jean-Luc Canon, Christian Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius Waller, David Waterhouse, Bruno Coudert, Zsuzsanna Mark, Miyako Satouchi, Gee-Chen Chang, Christian Herzmann, Arvind Chaudhry, Selvaraj Giridharan, Paul Hesketh, Norihiko Ikeda, Ralph Boccia, Nichola Iannotti, Missak Haigentz, John Reynolds, John Querol, Kazuhiko Nakagawa, Shunichi Sugawara, Eng Huat Tan, Tomonori Hirashima, Scott Gettinger, Terufumi Kato, Koji Takeda, Oscar Juan Vidal, Andrea Mohn-Staudner, Amit Panwalkar, Davey Daniel, Kunihiko Kobayashi, Guia Elena Imelda Ladrera, Clemens Schulte, Martin Sebastian, Marketa Cernovska, Helena Coupkova, Libor Havel, Norbert Pauk, Joginder Singh, Shuji Murakami, Tibor Csoszi, Gyorgy Losonczy, Allan Price, Ian Anderson, Mussawar Iqbal, Vamsee Torri, Erzsebet Juhasz, Saleem Khanani, Leona Koubkova, Benjamin Levy, Ray Page, Csaba Bocskei, Lucio Crinò, David Einspahr, Christopher Hagenstad, Necy Juat, Lindsay Overton, Mitchell Garrison, Zsuzsanna Szalai
Publikováno v:
Lancet Oncology
Lancet Oncology, 2020, 19 (4), pp.521-536. ⟨10.1016/s1470-2045(18)30144-x⟩
Lancet Oncol
Lancet Oncology, 2020, 19 (4), pp.521-536. ⟨10.1016/s1470-2045(18)30144-x⟩
Lancet Oncol
Background: Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without EGFR tyrosine kinase or anaplastic lymphoma kinase (ALK) genetic aberrations (EGFR−/ALK−), but clinical bene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00025c91c5f85bf7d8b98d17aae85fd1
https://hal.u-pec.fr/hal-04145965/document
https://hal.u-pec.fr/hal-04145965/document
Autor:
Helmut H. Popper, Ulrike Gruber-Mösenbacher, Georg Hutarew, Maximilian Hochmair, Gudrun Absenger, Luka Brcic, Leonhard Müllauer, Gerhard Dekan, Ulrike Setinek, Dagmar Krenbek, Michael Vesely, Robert Pirker, Wolfgang Hilbe, Rainer Kolb, Gerald Webersinke, Tamara Hernler, Georg Pall, Sigurd Lax, Andrea Mohn-Staudner
Publikováno v:
memo - Magazine of European Medical Oncology. 9:191-200
Autor:
Peter Schenk, Maximilian Hochmair, Petra Feurstein, Marie-Kathrin Breyer, Andrea Schrott, Wolfgang Pohl, Peter Errhalt, Michael Rolf Mueller, Otto C. Burghuber, Josef Eckmayr, Andrea Mohn-Staudner, Peter Cerkl, Klaus Kirchbacher, Meinhard Kneussl, Sylvia Hartl, Michael Studnicka, Bernhard Baumgartner, Friedrich Renner, Bernd Lamprecht, Josef Bolitschek
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights. Oncology
Objectives: The Austrian Lung Cancer Audit (ALCA) is a pilot study to evaluate clinical and organizational factors related to lung cancer care across Austria. Materials and methods: The ALCA is a prospective, observational, noninterventional cohort s
Autor:
Viljem Kovac, Lilla Tamási, Marco Siano, Thomas Brodowicz, Dimitar Kalev, G. Holzer, Mounir Bachouchi, Ufuk Abacioglu, Fulden Yumuk, Daniel M. Aebersold, Rabab Gaafar, Andrea Mohn-Staudner, Ewa Kalinka-Warzocha, Wolfgang Hilbe
Publikováno v:
memo - Magazine of European Medical Oncology. 6:75-82
Skeletal-related events represent a substantial burden for patients with advanced cancer. Randomized, controlled studies suggested superiority of denosumab over zoledronic acid in the prevention of skeletal-related events in metastatic cancer patient
Autor:
Peter Schenk, Robert Pirker, Andrea Mohn-Staudner, Ulrike Setinek, Sophia Holzer, Otto C. Burghuber, Martin Filipits, Anna Buder, Tatjana Bundalo, Peter Errhalt, Maximilian Hochmair
Publikováno v:
Journal of Thoracic Oncology. 12:S1205-S1206
Autor:
Michael Studnicka, Helmut Popper, Robert Pirker, Fritz Wrba, Wolfgang Hulla, Wolfgang Hilbe, Ulrike Gruber-Mösenbacher, Ferdinand Ploner, Andrea Mohn-Staudner
Publikováno v:
memo - Magazine of European Medical Oncology. 4:248-253
Patients with stage IIIB and IV non-small-cell lung carcinoma (NSCLC) harbouring activating mutations of the epidermal growth factor receptor (EGFR) gene should be treated first-line with gefitinib or erlotinib, EGFR tyrosine kinase inhibitors (TKI).
Autor:
Helmut Popper, Ferdinand Ploner, Andrea Mohn-Staudner, Wolfgang Hilbe, Fritz Wrba, Ulrike Gruber-Mösenbacher, Michael Studnicka, Robert Pirker, Wolfgang Hulla, und die Arbeitsgruppe Pulmopathologie der Ögp-Iap
Publikováno v:
Wiener klinische Wochenschrift. 123:316-321
Patients with stage IIIB and IV non-small cell lung carcinoma (NSCLC) harboring an activating mutation of the Epidermal Growth Factor Receptor (EGFR) Gene should be treated first-line with Gefitinib, an EGFR tyrosine kinase inhibitor (TKI). EGF recep
Autor:
Kurt Aigner, Robert Pirker, Josef Eckmayr, Richard Greil, Johannes Rothmund, Herbert Jamnig, Michael Studnicka, Alois Lang, Ferdinand Ploner, Andrea Mohn-Staudner, Lothar Schiller, Christian Dittrich, Sabine Zöchbauer-Müller, Herwig Schinko, Michael Fiegl, August Zabernigg, Martin Flicker, Bernhard Forstner, Wolfgang Hilbe, G. Krajnik
Publikováno v:
Wiener klinische Wochenschrift. 119:259-266
Autor:
Kurt Patocka, Dagmar Krenbek, Tatjana Bundalo, Klaus Kirchbacher, Hannah Fabikan, Ulrike Setinek, Sophia Holzer, Maximilian Hochmair, Andrea Mohn-Staudner, Otto C. Burghuber, Madeleine Arns, Rosemarie Rumbold
Publikováno v:
Journal of Thoracic Oncology. 12:S596